HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $232,000 | +30.3% | 15,805 | +4.4% | 1.09% | -2.7% |
| Q1 2020 | $178,000 | -50.4% | 15,135 | -1.0% | 1.12% | -26.0% |
| Q4 2019 | $359,000 | -14.3% | 15,295 | -32.5% | 1.52% | -14.0% |
| Q3 2019 | $419,000 | -2.6% | 22,665 | -6.0% | 1.76% | +12.3% |
| Q2 2019 | $430,000 | -10.0% | 24,112 | +23.3% | 1.57% | -17.4% |
| Q1 2019 | $478,000 | +38.6% | 19,553 | +47.0% | 1.90% | -14.7% |
| Q4 2018 | $345,000 | +1.8% | 13,299 | +24.3% | 2.23% | +27.4% |
| Q3 2018 | $339,000 | -58.9% | 10,696 | -49.6% | 1.75% | -52.3% |
| Q2 2018 | $825,000 | -10.5% | 21,233 | -36.4% | 3.66% | -5.6% |
| Q1 2018 | $922,000 | +50.4% | 33,389 | -1.4% | 3.88% | +39.8% |
| Q4 2017 | $613,000 | +14.2% | 33,875 | +1.8% | 2.78% | +9.8% |
| Q3 2017 | $537,000 | +5.5% | 33,274 | -9.4% | 2.53% | +5.2% |
| Q2 2017 | $509,000 | – | 36,744 | – | 2.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |